BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 22582479)

  • 1. Acute myocardial infarction during the early postpartum period successfully treated with tirofiban.
    Aksakal E; Inci S; Sevimli S; Karakelleoğlu S
    Eur Rev Med Pharmacol Sci; 2012 Mar; 16 Suppl 1():22-4. PubMed ID: 22582479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.
    Cannon CP; Weintraub WS; Demopoulos LA; Vicari R; Frey MJ; Lakkis N; Neumann FJ; Robertson DH; DeLucca PT; DiBattiste PM; Gibson CM; Braunwald E;
    N Engl J Med; 2001 Jun; 344(25):1879-87. PubMed ID: 11419424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjunctive therapies in the cath lab. Combination of tirofiban and alteplase in acute myocardial infarction.
    Arjomand H; Sokil AB; Arjmand R; Fischer HA; Wolf NM
    J Invasive Cardiol; 2001 Sep; 13(9):647-50. PubMed ID: 11533504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombus aspiration plus intra-infarct-related artery administration of tirofiban improves myocardial perfusion during primary angioplasty for acute myocardial infarction.
    Yan HB; Li SY; Song L; Wang J; Wu Z; Chi YP; Zheng B; Zhao HJ; Li QX; Zhang XJ; Li WZ
    Chin Med J (Engl); 2010 Apr; 123(7):877-83. PubMed ID: 20497681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tirofiban for myocardial infarction.
    Juwana YB; Suryapranata H; Ottervanger JP; van 't Hof AW
    Expert Opin Pharmacother; 2010 Apr; 11(5):861-6. PubMed ID: 20210689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facilitation of primary coronary angioplasty by early start of a glycoprotein 2b/3a inhibitor: results of the ongoing tirofiban in myocardial infarction evaluation (On-TIME) trial.
    van 't Hof AW; Ernst N; de Boer MJ; de Winter R; Boersma E; Bunt T; Petronio S; Marcel Gosselink AT; Jap W; Hollak F; Hoorntje JC; Suryapranata H; Dambrink JH; Zijlstra F;
    Eur Heart J; 2004 May; 25(10):837-46. PubMed ID: 15140531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of platelet glycoprotein IIb/IIIa receptor blockade with tirofiban on adverse cardiac events in women with unstable angina/non-ST-elevation myocardial infarction (PRISM-PLUS Study).
    Huynh T; Theroux P; Snapinn S; Wan Y;
    Am Heart J; 2003 Oct; 146(4):668-73. PubMed ID: 14564321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfer with GP IIb/IIIa inhibitor tirofiban for primary percutaneous coronary intervention vs. on-site thrombolysis in patients with ST-elevation myocardial infarction (STEMI): a randomized open-label study for patients admitted to community hospitals.
    Dobrzycki S; Kralisz P; Nowak K; Prokopczuk P; Kochman W; Korecki J; Poniatowski B; Zuk J; Sitniewska E; Bachorzewska-Gajewska H; Sienkiewicz J; Musial WJ
    Eur Heart J; 2007 Oct; 28(20):2438-48. PubMed ID: 17884846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of tirofiban in acute coronary syndromes.
    Gomma A; Collinson J; Purcell H; Flather M
    Int J Clin Pract; 2000 Mar; 54(2):121-4. PubMed ID: 10824369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful recanalization of an occluded coronary artery by percutaneous coronary intervention, systemic administration of tirofiban, a glycoprotein IIb/IIIa inhibitor, and intracoronary thrombolysis with alteplase.
    Meyners W; Peters S; Trümmel M; Koehler B
    Z Kardiol; 2004 May; 93(5):407-12. PubMed ID: 15160277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet inhibition by increased tirofiban dosing during primary coronary angioplasty for ST elevation myocardial infarction.
    Kralisz P; Dobrzycki S; Nowak K; Kochman W; Gajewska-Bachórzewska H; Gugała K; Mezyński G; Prokopczuk P; Zuk J; Korecki J; Poniatowski B; Musiał W
    Kardiol Pol; 2004 May; 60(5):459-67. PubMed ID: 15247961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of saphenous venous graft thrombus by tirofiban infusion.
    Sentürk T; Aydin Kaderli A; Aydin O; Yeşilbursa D; Akin Serdar O
    Heart Lung; 2010; 39(3):237-9. PubMed ID: 20457345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-ST-segment elevation myocardial infarction in a patient with essential thrombocythemia treated with glycoprotein IIb/IIIa inhibitor: a case report.
    Zhang Z; Wan X; Liu Y; Lin X; Ni Z; Yang X; Zhang L
    Clin Appl Thromb Hemost; 2011 Oct; 17(5):532-4. PubMed ID: 20724303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of glycoprotein IIb/IIIa inhibition on clinical stabilization parameters in patients with unstable angina and non-Q-wave myocardial infarction.
    Okmen E; Cakmak M; Tartan Z; Cam N
    Heart Vessels; 2003 Jul; 18(3):117-22. PubMed ID: 12955426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracoronary thrombus aspiration through a guiding catheter in a case with stent thrombosis.
    Turkoglu S; Simsek V; Timurkaynak T
    J Invasive Cardiol; 2008 Oct; 20(10):E304-5. PubMed ID: 18830012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of thrombolysis with alteplase (50 mg) plus tirofiban versus alteplase (100 mg) alone in acute myocardial infarction: preliminary findings.
    Sarullo FM; Pasquale PD; D'Alfonso G; Amerigo L; Cannizzaro S; Castello A
    Ital Heart J; 2001 Aug; 2(8):605-11. PubMed ID: 11577835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healing of spontaneous coronary dissection in the context of glycoprotein IIB/IIIA inhibitor therapy: a case report.
    Cheung S; Mithani V; Watson RM
    Catheter Cardiovasc Interv; 2000 Sep; 51(1):95-100. PubMed ID: 10973029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete thrombus resolution with tirofiban in obstructive mechanical prosthetic mitral valve thrombosis.
    Yuce M; Davutoglu V; Sari I; Cakici M; Ercan S
    Platelets; 2010; 21(5):386-8. PubMed ID: 20438393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early discharge is feasible following primary percutaneous coronary intervention with transradial stent implantation under platelet glycoprotein IIb/IIIa receptor blockade. Results of the AGGRASTENT Trial.
    Dirksen MT; Ronner E; Laarman GJ; van Heerebeek L; Slagboom T; van der Wieken LR; van der Wouw PA; Kiemeneij F
    J Invasive Cardiol; 2005 Oct; 17(10):512-7. PubMed ID: 16204742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of rotary pump thrombus with the glycoprotein IIb/IIIa inhibitor tirofiban.
    Thomas MD; Wood C; Lovett M; Dembo L; O'Driscoll G
    J Heart Lung Transplant; 2008 Aug; 27(8):925-7. PubMed ID: 18656810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.